Company Number: 14573517

Analysis Date: 2025-07-29 19:53 UTC

Financial Health Assessment for COPLASTIX LIMITED

---

1. Financial Health Score: D (Dormant / Minimal Activity)

Explanation:
COPLASTIX LIMITED is classified as a dormant company with minimal financial activity and negligible net assets (£1). This status means there are no active trading operations or significant financial transactions. While the company is compliant with filing obligations and maintains a clear ownership structure, the lack of operational data and financial activity limits a meaningful assessment of financial vitality. The score D reflects a "dormant" state rather than distress but highlights the absence of measurable financial health indicators.

---

2. Key Vital Signs

Metric	Value	Interpretation
Net Assets	£1	Virtually no equity; company is essentially inactive.
Shareholders Funds	£1	Minimal shareholder investment, typical for dormant firms.
Account Status	Dormant	No trading or significant transactions reported.
Filing Compliance	Up to date	Accounts and filings submitted timely, indicating good governance.
Director and PSC	Single Director and Owner (James O’Toole)	Strong control and clear accountability.
SIC Code	99999 (Dormant)	Officially recognized as dormant, no active industry classification.

Interpretation:
The company exhibits the "vital signs" of a dormant entity: negligible financial activity, minimal assets, but good administrative compliance. This resembles a patient in a resting state with no active symptoms or distress but also no active metabolic processes.

---

3. Diagnosis

COPLASTIX LIMITED is currently in a dormant state, showing no symptoms of operational activity or financial stress. The company’s balance sheet is minimal, reflecting only the nominal share capital. This dormancy indicates either a preparatory phase before commencing trade or a holding structure without current business operations.

The financial "pulse" is flat—no cash flow, no liabilities, no revenue. The governance "immune system" is intact, with timely filings and clear director responsibility, which reduces the risk of regulatory complications.

However, the absence of active trading means there is no evidence of business growth, profitability, or cash generation. This can be viewed as a neutral state—neither healthy growth nor distress—but also a lack of financial vitality.

---

4. Prognosis

If the company remains dormant, it will continue to exhibit stable but inactive financial health. Without active trading, the company poses minimal financial risk but also no opportunity for value creation.

Should the company plan to transition to active trading, the future financial outlook will depend on the successful launch and growth of operations, requiring monitoring of liquidity, sales growth, and profitability metrics to detect early symptoms of distress or success.

---

5. Recommendations

• Activate Financial Activity: If business operations are planned, establish clear budgets and financial controls to monitor cash flow and profitability from the outset.
• Maintain Compliance: Continue timely filing of accounts and confirmation statements to avoid legal penalties and maintain good standing.
• Prepare for Growth: Develop a financial plan including working capital needs and forecasted revenues before initiating trading activity.
• Monitor Director Responsibilities: Given sole control by one individual, consider appointing additional oversight or advisory roles to enhance governance as business complexity grows.
• Assess Market Opportunities: Engage in market research and strategic planning to ensure that when operations commence, the company has a clear path to sustainable revenue generation.

---